These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 21798030)

  • 21. Screening for oral potentially malignant epithelial lesions and squamous cell carcinoma: a discussion of benefit and risk.
    Epstein JB
    J Can Dent Assoc; 2014; 80():e47. PubMed ID: 25055237
    [No Abstract]   [Full Text] [Related]  

  • 22. Oral premalignancy: new methods of detection and treatment.
    Gillenwater A; Papadimitrakopoulou V; Richards-Kortum R
    Curr Oncol Rep; 2006 Mar; 8(2):146-54. PubMed ID: 16507225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Current concepts in diagnosis and treatment of oral malignant tumors].
    Hullmann MM; Reichert TE
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Sep; 54(9):1083-8. PubMed ID: 21887623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Screening and diagnosis of precancerous oral mucosa lesions].
    Reychler H; Weynand B
    Rev Stomatol Chir Maxillofac; 2010 Sep; 111(4):203-7. PubMed ID: 20797741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral Squamous Cell Carcinoma Associated with Precursor Lesions.
    McCord C; Kiss A; Magalhaes MA; Leong IT; Jorden T; Bradley G
    Cancer Prev Res (Phila); 2021 Sep; 14(9):873-884. PubMed ID: 34193432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of a fluorescence visualization system for the detection of oral precancerous and early cancerous lesions.
    Ohnishi Y; Fujii T; Ugaki Y; Yasui H; Watanabe M; Dateoka S; Kakudo K
    Oncol Rep; 2016 Jul; 36(1):514-20. PubMed ID: 27121913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions.
    Macey R; Walsh T; Brocklehurst P; Kerr AR; Liu JL; Lingen MW; Ogden GR; Warnakulasuriya S; Scully C
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD010276. PubMed ID: 26021841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for oral premalignancy and cancer: what platform and which biomarkers?
    Lingen MW
    Cancer Prev Res (Phila); 2010 Sep; 3(9):1056-9. PubMed ID: 20798207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective, blinded comparison of cytology and DNA-image cytometry of brush biopsies for early detection of oral malignancy.
    Kämmerer PW; Koch FP; Santoro M; Babaryka G; Biesterfeld S; Brieger J; Kunkel M
    Oral Oncol; 2013 May; 49(5):420-6. PubMed ID: 23318121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjunctive diagnostic techniques for oral lesions of unknown malignant potential: Systematic review with meta-analysis.
    Fuller C; Camilon R; Nguyen S; Jennings J; Day T; Gillespie MB
    Head Neck; 2015 May; 37(5):755-62. PubMed ID: 24596227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjunctive Diagnostic Techniques for Oral and Oropharyngeal Cancer Discovery.
    Huber MA
    Dent Clin North Am; 2018 Jan; 62(1):59-75. PubMed ID: 29126494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toluidine blue staining for detection of oral premalignant lesions and carcinomas.
    Miller RL; Simms BW; Gould AR
    J Oral Pathol; 1988 Feb; 17(2):73-8. PubMed ID: 3134535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of toluidine blue in oral premalignant lesions and squamous cell carcinoma: continuing research and implications for clinical practice.
    Epstein JB; Sciubba J; Silverman S; Sroussi HY
    Head Neck; 2007 Oct; 29(10):948-58. PubMed ID: 17764090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colposcopy: a new ray in the diagnosis of oral lesions.
    Pallagatti S; Sheikh S; Puri N; Gupta D; Singh B
    Indian J Dent Res; 2011; 22(6):810-5. PubMed ID: 22484876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Earliest detection of oral cancer using non-invasive brush biopsy including DNA-image-cytometry: report on four cases.
    Remmerbach TW; Weidenbach H; Hemprich A; Böcking A
    Anal Cell Pathol; 2003; 25(4):159-66. PubMed ID: 14501082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Girod SC; Pfeiffer P; Ries J; Pape HD
    Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue.
    Epstein JB; Silverman S; Epstein JD; Lonky SA; Bride MA
    Oral Oncol; 2008 Jun; 44(6):538-44. PubMed ID: 17996486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorescence visualization improves the detection of oral, potentially malignant, disorders in population screening.
    Simonato LE; Tomo S; Scarparo Navarro R; Balbin Villaverde AGJ
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():74-78. PubMed ID: 31116999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytologic and DNA-cytometric early diagnosis of oral cancer.
    Remmerbach TW; Weidenbach H; Pomjanski N; Knops K; Mathes S; Hemprich A; Böcking A
    Anal Cell Pathol; 2001; 22(4):211-21. PubMed ID: 11564897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic devices for detecting oral cancer.
    Gurenlian JR
    J Dent Hyg; 2009; 83(4):177-8. PubMed ID: 19909635
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.